The Parkinson’s Institute and Clinical Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:The Parkinson's Institute and Clinical Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9344
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Parkinson’s Institute and Clinical Center (PICC) is a non-profit organization that offers basic and clinical research, clinical trials and patient care services for parkinson’s disease and neurological movement disorders. The organization discovers and develops new treatments to improve the life of the people suffering from parkinson’s disease. It provides comprehensive services including neurological evaluation and treatment, physical, occupational and speech therapy, patient education, and seminars for patients and caregivers. The organization also develops methods to evaluate diseases and their progression. It offers weekly exercise and therapy classes, and bimonthly seminars to improve patient knowledge. PICC is headquartered in Sunnyvale, California, the US.

The Parkinson’s Institute and Clinical Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Parkinson’s Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Parkinson’s Institute and Clinical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
The Parkinson’s Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Parkinson’s Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
The Parkinson’s Institute and Clinical Center, Medical Devices Deals, 2012 to YTD 2018 9
The Parkinson’s Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
The Parkinson’s Institute and Clinical Center, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Parkinson’s Institute and Clinical Center and Retrotope Enter into Partnership 11
Parkinson’s Institute and Clinical Center and Axial Biotherapeutics Enter into Co-Development Agreement 12
Parkinson’s Institute and Denali Therapeutics Enter into Agreement 13
India Globalization Capital Enters into Joint Development Agreement with The Parkinson’s Institute 14
Parkinson’s Institute and Clinical Center Enters into Agreement with Merck 15
BERG Partners with Parkinson’s Institute and Clinical Center 16
Biogen Enters into Agreement with Parkinson’s Institute and Clinical Center 17
Berg Pharma Enters Into Co-Development Agreement With Parkinson’s Institute 18
The Parkinson’s Institute and Clinical Center – Key Competitors 19
The Parkinson’s Institute and Clinical Center – Key Employees 20
The Parkinson’s Institute and Clinical Center – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Government and Public Interest 22
Jan 19, 2017: The Parkinson’s Institute and Clinical Center awarded $1.9 million from California Institute for Regenerative Medicine to study key protein implicated in Parkinson’s Disease 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare, Key Facts 2
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Parkinson's Institute and Clinical Center, Deals By Therapy Area, 2012 to YTD 2018 8
The Parkinson's Institute and Clinical Center, Medical Devices Deals, 2012 to YTD 2018 9
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Parkinson’s Institute and Clinical Center and Retrotope Enter into Partnership 11
Parkinson’s Institute and Clinical Center and Axial Biotherapeutics Enter into Co-Development Agreement 12
Parkinson's Institute and Denali Therapeutics Enter into Agreement 13
India Globalization Capital Enters into Joint Development Agreement with The Parkinson's Institute 14
Parkinson’s Institute and Clinical Center Enters into Agreement with Merck 15
BERG Partners with Parkinson's Institute and Clinical Center 16
Biogen Enters into Agreement with Parkinson's Institute and Clinical Center 17
Berg Pharma Enters Into Co-Development Agreement With Parkinson's Institute 18
The Parkinson's Institute and Clinical Center, Key Competitors 19
The Parkinson's Institute and Clinical Center, Key Employees 20

List of Figures
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Parkinson's Institute and Clinical Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
The Parkinson's Institute and Clinical Center, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[The Parkinson’s Institute and Clinical Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NV Nederlandse Gasunie:企業の戦略的SWOT分析
    NV Nederlandse Gasunie - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • MYnd Analytics Inc (MYND):製薬・医療:M&Aディール及び事業提携情報
    Summary MYnd Analytics Inc (MYnd Analytics), formerly CNS Response Inc, is a predictive analytics company. The company develops a decision support tool that assists physicians in the provision of personalized medication for individual patients suffering from mental health issues. It provides Psychia …
  • Otsuka Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Otsuka Pharmaceutical Co Ltd (OPC), a subsidiary of Otsuka Holdings Co Ltd is a provider of healthcare products. The company offers products which include pocari sweat, pocari sweat ion water, oronamin c, calorie mate, nature made, jerubure, jarinea, five mini, amino-value, enerugen, jog mat …
  • Bayer HealthCare Pharmaceuticals:医療機器:M&Aディール及び事業提携情報
    Summary Bayer HealthCare Pharmaceuticals (Bayer Healthcare), formerly Bayer Schering Pharma AG, a subsidiary of Bayer AG, is the pharmaceutical company that develops, manufactures and markets prescription products in the areas of general medicine and specialty medicine. The company offer prescriptio …
  • Crown Bioscience Inc (6554):製薬・医療:M&Aディール及び事業提携情報
    Summary Crown Bioscience Inc (Crown Bioscience) is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, onc …
  • Shionogi Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Shionogi Inc (Shionogi), a subsidiary of Shionogi & Co., Ltd, is a pharmaceutical company that develops and commercializes pharmaceutical products to address the unmet medical needs. The company offers a wide range of branded prescription products to treat chronic diseases. It markets produc …
  • Veolia Environnement S.A.:企業の戦略・SWOT・財務分析
    Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report Summary Veolia Environnement S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Immunomedics Inc (IMMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunomedics Inc (Immunomedics) is a clinical-stage bio-pharmaceutical company that researches, develops, manufactures and commercializes monoclonal antibody-based drugs for the treatment of cancer and autoimmune disorders. The company develops its candidates based on its proprietary technol …
  • Hugo Boss AG (BOSS):企業の財務・戦略的SWOT分析
    Hugo Boss AG (BOSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • WH Group Limited (288):企業の財務・戦略的SWOT分析
    WH Group Limited (288) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Caribbean Utilities Company, Ltd. (CUP.U):電力:M&Aディール及び事業提携情報
    Summary Caribbean Utilities Company, Ltd. (CUC) is a vertically integrated electricity utility. Through licenses with the Cayman Islands Government, the company generates, transmits, and distributes electricity. It produces electricity from diesel. CUC’s power utility system includes diesel engines, …
  • Elite Pharmaceuticals Inc (ELTP):企業の財務・戦略的SWOT分析
    Elite Pharmaceuticals Inc (ELTP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • PostNL N.V.:企業の戦略・SWOT・財務情報
    PostNL N.V. - Strategy, SWOT and Corporate Finance Report Summary PostNL N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Admiral Taverns Ltd.:企業の戦略・SWOT・財務情報
    Admiral Taverns Ltd. - Strategy, SWOT and Corporate Finance Report Summary Admiral Taverns Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Visterra Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Visterra Inc (Visterra), formerly Parasol Therapeutics Inc is a clinical-stage biopharmaceutical company that develops antibody therapies for the treatment of infectious diseases. The company develops precision antibody-based biological medicines for infectious and non-infectious diseases. I …
  • NanoVibronix Inc (NAOV):製品パイプライン分析
    Summary NanoVibronix Inc (NanoVibronix) is a medical device company that offers therapeutic ultrasound technology solutions. The company offers clinical applications such as catheter related injury and its complications, pain and soft tissue healing. It offers electronic unit that uses disposable pa …
  • Evgen Pharma Plc (EVG):企業の財務・戦略的SWOT分析
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a clinical-stage drug development company focused on the development of sulforaphane-based compounds for the treatment of cancer and neurological disease. Its pipeline product SFX-01 targets STAT3 signalling to inhibit stem-like c …
  • Colt Group Ltd:企業の戦略的SWOT分析
    Colt Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Misawa Homes Co., Ltd.:戦略・SWOT・企業財務分析
    Misawa Homes Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Misawa Homes Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆